Unknown PHASE2 INTERVENTIONAL 1-arm NCT02338505

Teleassisted Surgery for Gynecological Disease in Obese Patients - OB-ALFX (OB-ALFX)

Sponsor: Catholic University of the Sacred Heart

Conditions Benign, Premalignant and Malignant Gynecological Disease Confined to the Pelvis

Updated 6 times since 2017 Last updated: Jan 13, 2015 Started: Feb 28, 2015 Primary completion: Feb 29, 2016 Completion: Feb 29, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02338505, this PHASE2 trial focuses on Benign, Premalignant and Malignant Gynecological Disease Confined to the Pelvis and remains ongoing. Sponsored by Catholic University of the Sacred Heart, it has been updated 6 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Feb 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Catholic University of the Sacred Heart
SOFAR S.p.A.

Data source: Catholic University of the Sacred Heart

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rome, Italy